Tonix Pharmaceuticals Holding (TNXP) Assets Average (2011 - 2026)

Tonix Pharmaceuticals Holding has reported Assets Average for 16 years, with the latest figure at $256.0 million in Q2 2026.

• On a quarterly basis, Assets Average rose 34.66% year-over-year to $256.0 million in Q2 2026; TTM through Jun 2026 was $256.0 million, a 34.66% increase from a year earlier, with the FY2025 full-year figure at $220.0 million, up 38.67% from the prior year.
• Assets Average was $256.0 million for Q2 2026 at Tonix Pharmaceuticals Holding, down from $267.5 million in the prior quarter.
• The five-year high for Assets Average was $267.5 million in Q1 2026, with the low at $82.6 million in Q3 2024.
• Average Assets Average over 5 years is $193.3 million, with a median of $196.3 million recorded in 2023.
• The sharpest annual moves came in 2024 and 2025: Assets Average slumped 44.72% in 2024, then surged 166.07% in 2025.
• Over 5 years, Assets Average stood at $234.2 million in 2022, then tumbled by 37.28% to $146.9 million in 2023, then declined by 12.21% to $128.9 million in 2024, then soared by 105.37% to $264.8 million in 2025, then fell by 3.33% to $256.0 million in 2026.
• The last three Assets Average figures came in at $256.0 million (Q2 2026), $267.5 million (Q1 2026), and $264.8 million (Q4 2025), per Business Quant data.